Clinical Trial Update: Antibacterial Properties of Silicon Incorporated With Quaternary Ammonium Polyethylenimine Nanoparticles [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating antibacterial properties of silicon-incorporated quaternary ammonium polyethylenimine nanoparticles, sponsored by Hadassah …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Silicon Incorporated With Quaternary Ammonium Polyethylenimine Nanoparticles

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Carcinoma of Head and Neck | Phase 1 | Status: UNKNOWN